NCT00200434View on ClinicalTrials.gov

A Study of the Efficacy and Safety of Nebivolol Added to Existing Antihypertensive Treatment in Patients With Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

October 31, 2003

Conditions
Hypertension
Interventions
DRUG

Nebivolol

Trial Locations (1)

26505

Mylan Pharmaceuticals Inc., Morgantown

Sponsors
All Listed Sponsors
lead

Mylan Bertek Pharmaceuticals

INDUSTRY